Iterum Therapeutics Plc ITRM

NAS: ITRM | ISIN: IE00BF3W0Q35   3/05/2024
1,550 USD (-1,90%)
(-1,90%)   3/05/2024

30 januari 2024 · Iterum Therapeutics Announces Positive Topline Results from its Phase 3 REASSURE Clinical Trial of Oral Sulopenem in Uncomplicated Urinary Tract Infections · Persbericht

30 september 2021 · Antimicrobials Working Group Highlights Member Company Participation at IDWeek 2021 · Persbericht

27 september 2021 · Iterum Therapeutics Plc (Nasdaq: Itrm) October 4, 2021 Investor Filing Deadline: · Persbericht

25 september 2021 · ITRM UPCOMING DEADLINE: Investors with Substantial Losses Have Opportunity to Lead the Iterum Therapeutics plc Class Action Lawsuit · Persbericht

9 september 2021 · ITERUM THERAPEUTICS (NASDAQ: ITRM) INVESTOR FILING DEADLINE: Bernstein Liebhard Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Has Been Filed Against Iterum Therapeutics plc · Persbericht

27 augustus 2021 · Pomerantz Law Firm Announces the Filing of a Class Action Against Iterum Therapeutics plc and Certain Officers - ITRM · Persbericht

20 augustus 2021 · Pomerantz Law Firm Announces the Filing of a Class Action Against Iterum Therapeutics plc and Certain Officers - ITRM · Persbericht

16 augustus 2021 · ITRM INVESTOR FILING DEADLINE: Bernstein Liebhard Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Has Been Filed Against Iterum Therapeutics plc · Persbericht

12 augustus 2021 · Pomerantz Law Firm Announces the Filing of a Class Action Against Iterum Therapeutics plc and Certain Officers - ITRM · Persbericht

9 augustus 2021 · ITRM NOTICE: Investors with Substantial Losses Have Opportunity to Lead the Iterum Therapeutics plc Class Action Lawsuit · Persbericht

6 augustus 2021 · Pomerantz Law Firm Announces the Filing of a Class Action Against Iterum Therapeutics plc and Certain Officers - ITRM · Persbericht

5 augustus 2021 · Acurx Pharmaceuticals Joins the Antimicrobials Working Group · Persbericht

8 juni 2021 · Crestone Joins Antimicrobials Working Group · Persbericht

16 maart 2021 · Iterum Therapeutics Appoints Beth P. Hecht to Board of Directors · Persbericht

12 maart 2021 · Iterum Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results · Persbericht

5 maart 2021 · Iterum Therapeutics to Announce Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call on March 12, 2021 · Persbericht

19 februari 2021 · Iterum Therapeutics to Present in Upcoming Investor Conferences · Persbericht

17 februari 2021 · UTILITY Therapeutics Joins Antimicrobials Working Group · Persbericht

11 februari 2021 · Iterum Therapeutics plc Announces Exercise of Underwriter’s Option to Purchase Additional Ordinary Shares · Persbericht

10 februari 2021 · Iterum Therapeutics plc Announces $35.0 Million Registered Direct Offering of Ordinary Shares Priced At-the-Market under Nasdaq Rules · Persbericht

Mijn selecties